<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04943367</url>
  </required_header>
  <id_info>
    <org_study_id>Rocuronium injection pain</org_study_id>
    <nct_id>NCT04943367</nct_id>
  </id_info>
  <brief_title>Effect of TEAS on Rocuronium Injection Pain</brief_title>
  <official_title>Efficacy of TEAS On Prevention of Rocuronium Injection Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konya Meram State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konya Meram State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain from the injection of rocuronium is a common side effect during anesthetic practice,&#xD;
      occurring in 50%-80% of patients. Several methods have been used to reduce this pain. This&#xD;
      prospective, randomized study was designed to determine the efficacy of transcutaneous&#xD;
      electrical acupuncture point stimulation in reducing the rocuronium injection pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 12, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain with rocuronium injection</measure>
    <time_frame>5 minutes</time_frame>
    <description>pain will be graded as no pain; mild pain; moderate pain; severe pain following administration of a priming dose of rocuronium</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Injection Pain</condition>
  <arm_group>
    <arm_group_label>GROUP TEAS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive TEAS bilaterally at two acupoints: Hegu (L14) and Neiguan (PC6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Sham Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients in the sham group will be undergoing electrode attachment on the target acupoints without electronic stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TEAS</intervention_name>
    <description>Transcutaneous electrical acupuncture stimulation</description>
    <arm_group_label>Control Sham Group</arm_group_label>
    <arm_group_label>GROUP TEAS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-65 year aged&#xD;
&#xD;
          -  ASA I-III&#xD;
&#xD;
          -  Who was to undergo various elective operations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cardiovascular surgery&#xD;
&#xD;
          -  Patients with pacemakers&#xD;
&#xD;
          -  Patients requiring rapid sequential induction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Betul Kozanhan</name>
      <address>
        <city>Konya</city>
        <zip>42005</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betul Kozanhan</last_name>
      <phone>0 (332) 310 50 00</phone>
      <email>betulkozanhan@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>June 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2021</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konya Meram State Hospital</investigator_affiliation>
    <investigator_full_name>Betul Kozanhan</investigator_full_name>
    <investigator_title>Ass.Prof.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

